Circulating Biomarkers of Language Development in Single Ventricle Heart Disease

Kelly R. Wolfe,Lindsay M. Thomson,Sierra Niemiec,Christopher A. Mancuso,Ludmila Khailova,Benjamin S. Frank,Jesse A. Davidson
DOI: https://doi.org/10.1001/jamapediatrics.2024.2507
2024-10-08
JAMA Pediatrics
Abstract:Neurodevelopmental (ND) challenges are the most common long-term morbidity in single ventricle heart disease (SVHD), with high rates of early ND delays (>75%). 1 The etiology of ND impairment in SVHD remains elusive, with published models explaining only 30% to 45% of observed variability. 2 For premature neonates, biomarkers of acute neural injury provide mechanistic insight to ND outcomes and clinical utility for risk stratification. 3 However, in SVHD, acute neonatal neural injury occurs within the context of abnormal neural development beginning in the fetal period. 4 Incorporating biomarkers of abnormal neural development and neural injury with other risk factors 2 could therefore help create an optimal model for prognosticating ND risk in SVHD. A previous study 5 described widespread abnormalities in the circulating proteome in infants with SVHD, including 62 proteins functionally enriched for neural development, raising the question of whether these proteins were associated with ND. Here, we assess these 62 proteins measured in infancy and toddler-age ND outcomes in SVHD.
pediatrics
What problem does this paper attempt to address?